CVEvulnerability

CVE-2025-52653

5.4 MEDIUM Published 2025-10-03 Modified 2026-10-08 Official page ↗
Status
Analyzed
Published
2025-10-03
Last modified
2026-10-08
Assigner
[email protected]
CVSS 3.1 ([email protected])
7.6 HIGH — CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H
CVSS 3.1 ([email protected])
5.4 MEDIUM — CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Weaknesses
CWE-79

Description

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

Affected configurations

• hcltech dryice myxalytics 6.6

Related

Weakness · CWE (1)

  • CWE-79 Improper Neutralization of Input During Web Page Generation weakness

References